2002
DOI: 10.1107/s0907444902003451
|View full text |Cite
|
Sign up to set email alerts
|

The Protein Data Bank

Abstract: The Protein Data Bank [PDB; Berman, Westbrook et al. (2000), Nucleic Acids Res. 28, 235-242; http://www.pdb.org/] is the single worldwide archive of primary structural data of biological macromolecules. Many secondary sources of information are derived from PDB data. It is the starting point for studies in structural bioinformatics. This article describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information and plans for the future development of the reso… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

17
3,132
0
41

Year Published

2005
2005
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 3,496 publications
(3,191 citation statements)
references
References 21 publications
17
3,132
0
41
Order By: Relevance
“…In this case, the twin fraction was lower and refined to 0.05. The coordinates, structure factors, and intensities were deposited in PDB (41). Statistics describing the data and refinement are summarized in Table 1.…”
Section: Methodsmentioning
confidence: 99%
“…In this case, the twin fraction was lower and refined to 0.05. The coordinates, structure factors, and intensities were deposited in PDB (41). Statistics describing the data and refinement are summarized in Table 1.…”
Section: Methodsmentioning
confidence: 99%
“…Initial phases for BphB B-356 were obtained by molecular replacement using MOLREP from the CCP4 version 6.0 software suite (20). The crystal structure of BphB LB400 was used as a search model (Protein Data Bank (PDB) code 1BDB) (21). Rigid body refinement was followed by iterative cycles of restrained atomic parameter refinement using the programs CNS (22) and REFMAC_5.2 (23).…”
Section: Methodsmentioning
confidence: 99%
“…The popular structure-based approaches require the availability of a 3D structure for the biological target of interest, this information permitting the use of methods based on de novo design or ligand-protein docking [5][6][7], these methods becoming widely used with the continuing growth in the availability of 3D protein data [8,9]. If the necessary 3D information is not available then it may be possible to identify the structural requirements for activity by analysis of those structures that have already been shown to be active.…”
Section: Introductionmentioning
confidence: 99%